Gene, Cell and Tissue

Published by: Kowsar

Identification of Genes Involved in the Early Stages of Alzheimer Disease Using a Neural Network Algorithm

Marie Barati 1 and Mansour Ebrahimi 2 , *
Authors Information
1 University of Applied Science and Technology Centre of Nehbandan, Nehbandan, IR Iran
2 Department of Biology, School of Basic Sciences, University of Qom, Qom, IR Iran
Article information
  • Gene, Cell and Tissue: July 01, 2016, 3 (3); e38415
  • Published Online: July 12, 2016
  • Article Type: Research Article
  • Received: April 13, 2016
  • Revised: June 20, 2016
  • Accepted: June 26, 2016
  • DOI: 10.17795/gct-38415

To Cite: Barati M, Ebrahimi M. Identification of Genes Involved in the Early Stages of Alzheimer Disease Using a Neural Network Algorithm, Gene Cell Tissue. 2016 ; 3(3):e38415. doi: 10.17795/gct-38415.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Discussion
  • 1. Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging. 1998; 19(3): 173-89[PubMed]
  • 2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998; 88(9): 1337-42[PubMed]
  • 3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007; 3(3): 186-91[DOI][PubMed]
  • 4. Perl DP. Neuropathology of Alzheimer's disease. Mt Sinai J Med. 2010; 77(1): 32-42[DOI][PubMed]
  • 5. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007; 14(1): 1-26[DOI][PubMed]
  • 6. Alzheimer's A. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011; 7(2): 208-44[DOI][PubMed]
  • 7. Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol. 2005; 58(1): 155-60[DOI][PubMed]
  • 8. Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 2(3): 6312[DOI][PubMed]
  • 9. Molsa PK, Marttila RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1986; 74(2): 103-7[PubMed]
  • 10. Lin CH, Chen PK, Chang YC, Chuo LJ, Chen YS, Tsai GE, et al. Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial. Biol Psychiatry. 2014; 75(9): 678-85[DOI][PubMed]
  • 11. Ory MG, Hoffman R, Yee JL, Tennstedt S, Schulz R. Prevalence and impact of caregiving: a detailed comparison between dementia and nondementia caregivers. Gerontologist. 1999; 39(2): 177-85[PubMed]
  • 12. Meek PD, McKeithan K, Schumock GT. Economic considerations in Alzheimer's disease. Pharmacotherapy. 1998; 18(2 Pt 2): 68-73[PubMed]
  • 13. Zhu CW, Sano M. Economic considerations in the management of Alzheimer's disease. Clin Interv Aging. 2006; 1(2): 143-54[PubMed]
  • 14. deFigueiredo RJ, Shankle WR, Maccato A, Dick MB, Mundkur P, Mena I, et al. Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single photon emission with computed tomography image data from brain. Proc Natl Acad Sci U S A. 1995; 92(12): 5530-4[PubMed]
  • 15. Ebrahimie E, Ebrahimi M, Sarvestani NR, Ebrahimi M. Protein attributes contribute to halo-stability, bioinformatics approach. Saline Systems. 2011; 7(1): 1[DOI][PubMed]
  • 16. RapidMiner Technical Support.
  • 17. Hardman JGLL, Gilman AG. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 2001; : 2045
  • 18. Assistive technology for promoting physical and mental exercise to delay progression of cognitive degeneration in patients with dementia. 2007 ieee biomedical circuits and systems conference. : 235-8
  • 19. Adomas A, Heller G, Olson A, Osborne J, Karlsson M, Nahalkova J, et al. Comparative analysis of transcript abundance in Pinus sylvestris after challenge with a saprotrophic, pathogenic or mutualistic fungus. Tree Physiol. 2008; 28(6): 885-97[PubMed]
  • 20. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001; 20(11): 683-95[DOI][PubMed]
  • 21. Arisi I, D'Onofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G, et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J Alzheimers Dis. 2011; 24(4): 721-38[DOI][PubMed]
  • 22. Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M. Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life. 2004; 56(6): 349-54[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments